Considering benefit and risk before routinely recommending SpaceOAR.
作者信息
Hall William A, Tree Alison C, Dearnaley David, Parker Christopher C, Prasad Vinay, Roach Mack, Lawton Colleen A F
机构信息
Department of Radiation Oncology, Medical College of Wisconsin, WI 53226, USA.
The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
出版信息
Lancet Oncol. 2021 Jan;22(1):11-13. doi: 10.1016/S1470-2045(20)30639-2.
Abstract
摘要
相似文献
1
Considering benefit and risk before routinely recommending SpaceOAR.在常规推荐使用SpaceOAR之前，需权衡利弊。
Lancet Oncol. 2021 Jan;22(1):11-13. doi: 10.1016/S1470-2045(20)30639-2.
2
Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.在高剂量率近距离放射治疗期间使用SpaceOAR改善直肠剂量测定法。
Brachytherapy. 2018 Mar-Apr;17(2):259-264. doi: 10.1016/j.brachy.2017.10.014. Epub 2017 Dec 2.
3
Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.在接受钯-103低剂量率近距离放射治疗的患者中放置可吸收直肠水凝胶间隔物。
Brachytherapy. 2018 Mar-Apr;17(2):251-258. doi: 10.1016/j.brachy.2017.11.006. Epub 2017 Dec 11.
4
Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications.减少前列腺（125）I 粒子植入治疗的植入针数量：可能性与影响的研究
Brachytherapy. 2010 Oct-Dec;9(4):319-27. doi: 10.1016/j.brachy.2009.07.010. Epub 2010 Aug 6.
5
Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR.急性患者报告的肠道生活质量以及前列腺外照射放疗、低剂量率近距离放疗增敏和SpaceOAR联合治疗后的直肠出血情况。
Brachytherapy. 2020 Jul-Aug;19(4):477-483. doi: 10.1016/j.brachy.2020.03.006. Epub 2020 Apr 21.
6
Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy.前列腺近距离放射治疗期间与SpaceOAR水凝胶插入相关的直肠溃疡
BMJ Case Rep. 2014 Dec 22;2014:bcr2014206931. doi: 10.1136/bcr-2014-206931.
7
[Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].[永久性植入前列腺癌近距离放射治疗：2013年技术现状]
Cancer Radiother. 2013 Apr;17(2):111-7. doi: 10.1016/j.canrad.2013.01.009. Epub 2013 Mar 9.
8
Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.聚乙二醇水凝胶直肠间隔植入术在接受高剂量率近距离放疗和外照射放疗联合治疗的前列腺癌患者中的应用
Brachytherapy. 2016 May-Jun;15(3):283-287. doi: 10.1016/j.brachy.2015.12.007. Epub 2016 Feb 4.
9
Prostate displacement kit: reducing the radiation dose to the rectum.前列腺移位套件：降低直肠的辐射剂量。
Radiother Oncol. 2006 Dec;81(3):291-3. doi: 10.1016/j.radonc.2006.10.027. Epub 2006 Nov 27.
10
Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.前列腺癌：远距离放疗和近距离放疗中的生物剂量考量与限制
Strahlenther Onkol. 2007 Dec;183 Spec No 2:14-5. doi: 10.1007/s00066-007-2006-5.
引用本文的文献
1
Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer.对于局限性前列腺癌，在不使用基准标记或直肠周围水凝胶间隔物的情况下进行局部加量的立体定向体部放疗的毒性特征和临床结果。
Strahlenther Onkol. 2024 Dec 10. doi: 10.1007/s00066-024-02333-4.
2
Depth of Hydrogel Spacer Rectal Wall Infiltration Was Not Associated With Rectal Toxicity: Results From a Randomized Prospective Trial.水凝胶间隔物直肠壁浸润深度与直肠毒性无关：一项随机前瞻性试验的结果
Adv Radiat Oncol. 2024 Sep 11;9(12):101624. doi: 10.1016/j.adro.2024.101624. eCollection 2024 Dec.
3
Hydrogels in the clinic: An update.临床中的水凝胶：最新进展。
Bioeng Transl Med. 2024 May 16;9(6):e10680. doi: 10.1002/btm2.10680. eCollection 2024 Nov.
4
The impact of rectal spacers in MR-guided adaptive radiotherapy.直肠间隔器在磁共振引导下的自适应放疗中的影响。
Clin Transl Radiat Oncol. 2024 Oct 1;49:100872. doi: 10.1016/j.ctro.2024.100872. eCollection 2024 Nov.
5
SpaceOAR Complication Affecting the Treatment of Prostate Cancer.影响前列腺癌治疗的SpaceOAR并发症
Cureus. 2024 Apr 17;16(4):e58485. doi: 10.7759/cureus.58485. eCollection 2024 Apr.
6
Management of the Devastated Bladder Outlet after Prostate CANCER Treatment.前列腺癌治疗后膀胱出口损毁的处理。
Curr Urol Rep. 2024 Jul;25(7):149-162. doi: 10.1007/s11934-024-01206-8. Epub 2024 May 16.
7
In Curative Stereotactic Body Radiation Therapy for Prostate Cancer, There Is a High Possibility That 45 Gy in Five Fractions Will Not Be Tolerated without a Hydrogel Spacer.在前列腺癌的根治性立体定向体部放射治疗中，如果没有水凝胶间隔物，五分次给予45 Gy很可能无法耐受。
Cancers (Basel). 2024 Apr 11;16(8):1472. doi: 10.3390/cancers16081472.
8
A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging.一种用于前列腺癌中等分割放疗的新型水凝胶原位注射模型：适应性降解与持久成像
Front Oncol. 2023 Jan 13;12:1077900. doi: 10.3389/fonc.2022.1077900. eCollection 2022.
9
A case report: Retrograde arterial embolization of locally-injected SpaceOAR hydrogel material into the right common iliac artery bifurcation.病例报告：局部注射到右髂总动脉分叉处的SpaceOAR水凝胶材料逆行动脉栓塞
Radiol Case Rep. 2022 Dec 12;18(2):719-726. doi: 10.1016/j.radcr.2022.02.042. eCollection 2023 Feb.
10
Rectal retractor in prostate radiotherapy: pros and cons.直肠牵开器在前列腺放射治疗中的利弊。
Radiat Oncol. 2022 Dec 9;17(1):204. doi: 10.1186/s13014-022-02176-2.
本文引用的文献
1
Aminsharifi et al., Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database (From: Aminsharifi A, Kotamarti S, Silver D, et al., J Endourol 2019;33:868-871; DOI: 10.1089/end.2019.0431).阿米尼沙里菲等人，与前列腺癌放疗前注射SpaceOAR水凝胶系统相关的主要并发症和不良事件：制造商和用户设施设备经验数据库综述（来自：阿米尼沙里菲A、科塔马尔蒂S、西尔弗D等人，《腔内泌尿外科杂志》2019年；33:868 - 871；DOI: 10.1089/end.2019.0431）
J Endourol. 2020 Feb;34(2):240-241. doi: 10.1089/end.2019.0742.
2
Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database.前列腺癌放疗前注射 SpaceOAR 水凝胶系统的主要并发症和不良事件：制造商和用户设施设备经验数据库的回顾。
J Endourol. 2019 Oct;33(10):868-871. doi: 10.1089/end.2019.0431. Epub 2019 Sep 27.
3
Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.评估水凝胶直肠间隔器在前列腺癌放射治疗中的成本效益。
Pract Radiat Oncol. 2019 Mar;9(2):e172-e179. doi: 10.1016/j.prro.2018.10.003. Epub 2018 Oct 17.
4
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.标准剂量与剂量递增放疗治疗中危前列腺癌患者的效果：NRG 肿瘤学 RTOG 0126 随机临床试验。
JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039.
5
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.前列腺放射治疗中直肠分离的持续获益：一项III期试验的最终结果
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):976-985. doi: 10.1016/j.ijrobp.2016.12.024. Epub 2016 Dec 23.
6
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.常规分割与大分割高剂量调强放疗治疗前列腺癌：随机、非劣效性3期CHHiP试验的5年结果
Lancet Oncol. 2016 Aug;17(8):1047-1060. doi: 10.1016/S1470-2045(16)30102-4. Epub 2016 Jun 20.
7
Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.水凝胶 spacer 前瞻性多中心随机对照关键试验：经直肠 spacer 应用于接受前列腺图像引导调强放疗的男性患者的剂量学和临床效果。
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-977. doi: 10.1016/j.ijrobp.2015.04.030. Epub 2015 Apr 23.
8
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors.在具有测量量表结局的随机临床试验中存在观察者偏倚：对具有盲法和非盲法评估者的试验进行的系统评价。
CMAJ. 2013 Mar 5;185(4):E201-11. doi: 10.1503/cmaj.120744. Epub 2013 Jan 28.
9
How to spot bias and other potential problems in randomised controlled trials.如何在随机对照试验中发现偏倚及其他潜在问题。
J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):181-7. doi: 10.1136/jnnp.2003.025833.
Zotero 插件